Spruce Biosciences (SPRB)

• Market cap: $127M
• 1 day: -0.59%
• 5 days: 11.22%
• 1 month: -8.52%
• 3 months: 1,117.24%
• 6 months: 1,117.24%
• Year to date: 279.18%
• 1 year: 192.31%
• 5 years: -91.16%
• 10 years: -90.64%
• Sector: Healthcare
• Industry: Biotechnology

About: Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The pipeline products of the company include Tralesinidase Alfa (TA-ERT), and Tildacerfont/ Cortibon, a Companion Diagnostic, developed in partnership with HMNC Brain Health.

Employees: 20